Macquarie Group’s Neuronetics STIM Stock Holding History

Macquarie Group’s Portfolio STIM Stock Details STIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-15,886	Closed	-$423K	–	2263
2018 Q2	$423K	Buy	+15,886	New	+$432K	﹤0.01%	1416

Other funds holding STIM

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

IVM

InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Macquarie Group's STIM Position: Q3 2018 in Review

Macquarie Group sold out of Neuronetics (STIM) in Q3 2018, closing a stake of 15,886 shares — an estimated $423K sold.

Macquarie Group first reported a position in STIM in Q2 2018 and held it in 1 quarter. The position peaked at $423K in Q2 2018. 74 funds tracked by Wall St. Rank hold STIM as of Q3 2018.

Macquarie Group reported no remaining Neuronetics position as of Q3 2018 after selling out during the quarter.
Macquarie Group sold 15,886 Neuronetics shares in Q3 2018, an estimated $423K.
Macquarie Group first reported a position in Neuronetics in Q2 2018 and held it in 1 quarter.
Macquarie Group's Neuronetics position peaked at $423K in Q2 2018.
74 funds tracked by Wall St. Rank held Neuronetics as of Q3 2018.

Based on Macquarie Group's 13F filing for Q3 2018, filed 15 Nov 2018.